The "Lazarus Response" in Treatment-Naive, Poor Performance Status Patients With Non-Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Mutation

被引：51
作者：
Langer, Corey J. [1 ]
机构：
[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 09期
关键词：
PHASE-III TRIAL; PACLITAXEL POLIGLUMEX CT-2103; SINGLE-AGENT GEMCITABINE; PS; PATIENTS; 1ST-LINE GEFITINIB; PLUS CARBOPLATIN; RANDOMIZED TRIAL; CHEMOTHERAPY; ERLOTINIB; COMBINATION;
D O I：
10.1200/JCO.2008.20.4859
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1350 / 1354
页数：5
相关论文
共 42 条
[1]   A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations [J].
Asahina, H. ;
Yamazaki, K. ;
Kinoshita, I. ;
Sukoh, N. ;
Harada, M. ;
Yokouchi, H. ;
Ishida, T. ;
Ogura, S. ;
Kojima, T. ;
Okamoto, Y. ;
Fujita, Y. ;
Dosaka-Akita, H. ;
Isobe, H. ;
Nishimura, M. .
BRITISH JOURNAL OF CANCER, 2006, 95 (08) :998-1004
[2]   Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21 [J].
Clark, Gary M. ;
Zborowski, Denni M. ;
Santabarbara, Pedro ;
Ding, Keyue ;
Whitehead, Marlo ;
Seymour, Lesley ;
Shepherd, Frances A. .
CLINICAL LUNG CANCER, 2006, 7 (06) :389-394
[3]   Lung cancer outcomes at a UK cancer unit between 1998-2001 [J].
Free, C. M. ;
Ellis, M. ;
Beggs, L. ;
Beggs, D. ;
Morgan, S. A. ;
Baldwin, D. R. .
LUNG CANCER, 2007, 57 (02) :222-228
[4]   Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: The Tarceva Lung Cancer Investigation Trial [J].
Gatzemeier, Ulrich ;
Pluzanska, Anna ;
Szczesna, Aleksandra ;
Kaukel, Eckhard ;
Roubec, Jaromir ;
De Rosa, Flavio ;
Milanowski, Janusz ;
Karnicka-Mlodkowski, Hanna ;
Pesek, Milos ;
Serwatowski, Piotr ;
Ramlau, Rodryg ;
Janaskova, Terezie ;
Vansteenkiste, Johan ;
Strausz, Janos ;
Manikhas, Georgy Moiseevich ;
Von Pawel, Joachim .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) :1545-1552
[5]   Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase III trial-INTACT1 [J].
Giaccone, G ;
Herbst, RS ;
Manegold, C ;
Scagliotti, G ;
Rosell, R ;
Miller, V ;
Natale, RB ;
Schiller, JH ;
von Pawel, J ;
Pluzanska, A ;
Gatzemeier, M ;
Grous, J ;
Ochs, JS ;
Averbuch, SD ;
Wolf, MK ;
Rennie, P ;
Fandi, A ;
Johnson, DH .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :777-784
[6]  
Gridelli C, 1999, JNCI-J NATL CANCER I, V91, P66
[7]   Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial - INTACT 2 [J].
Herbst, RS ;
Giaccone, G ;
Schiller, JH ;
Natale, RB ;
Miller, V .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :785-794
[8]   TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer [J].
Herbst, RS ;
Prager, D ;
Hermann, R ;
Fehrenbacher, L ;
Johnson, BE ;
Sandler, A ;
Kris, MG ;
Tran, HT ;
Klein, P ;
Li, X ;
Ramies, D ;
Johnson, DH ;
Miller, VA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5892-5899
[9]   Southwest oncology group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2 [J].
Hesketh, Paul J. ;
Chansky, Kari ;
Wozniak, Antoinette J. ;
Hirsch, Fred R. ;
Spreafico, Anna ;
Moon, James. ;
Mack, Philip C. ;
Marchello, Benjamin T. ;
Franklin, Wilbur A. ;
Crowley, John J. ;
Gandara, David R. .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (09) :1026-1031
[10]   Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: A Southwest Oncology Group Study [J].
Hirsch, FR ;
Varella-Garcia, M ;
McCoy, J ;
West, H ;
Xavier, AC ;
Gumerlock, P ;
Bunn, PA ;
Franklin, WA ;
Crowley, J ;
Gandara, DR .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :6838-6845
12345